DETERMINATION OF PHENYLBUTAZONE IN PLASMA = DETERMINATION DE LA PHENYLBUTAZONE DANS LE PLASMAJAEHNCHEN E; LEVY G.1972; CLIN. CHEM.; U.S.A.; DA. 1972; VOL. 18; NO 9; PP. 984-986; BIBL. 10 REF.Serial Issue

ISOSORBIDE DINITRATE KINETICS AND DYNAMICS AFTER INTRAVENOUS, SUBLINGUAL, AND PERCUTANEOUS DOSING IN ANGINAMORRISON RA; WIEGAND UW; JAEHNCHEN E et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 19; NO 6; PP. 747-756; BIBL. 35 REF.Article

EFFECT OF INDUCTION AND INHIBITION OF DRUG METABOLISM ON PHARMACOKINETICS AND ANTICOAGULANT ACTIVITY OF THE ENANTIOMERS OF PHENPROCOUMON IN RATSSCHMIDT W; TRENK D; JAEHNCHEN E et al.1980; PHARMACOLOGY; ISSN 0031-7012; CHE; DA. 1980; VOL. 21; NO 5; PP. 313-322; BIBL. 2 P.Article

AZAPROPAZONE BINDING TO HUMAN SERUM ALBUMINFEHSKE K; JAEHNCHEN E; MUELLER WE et al.1980; NAUNYN. SCHMIEDEBERG ARCH. PHARMACOL.; ISSN 0369-5565; DEU; DA. 1980; VOL. 313; NO 2; PP. 159-163; BIBL. 26 REF.Article

SPECIES DIFFERENCES OF THE STEREOSELECTIVE BINDING OF PHENPROCOUMON AND WARFARIN ENANTIOMERS TO SERUM ALBUMINSBROWN NA; JAEHNCHEN E; MULLER WE et al.1979; COMP. BIOCHEM. PHYSIOL., C; GBR; DA. 1979; VOL. 62; NO 1; PP. 101-105; BIBL. 16 REF.Article

PHARMACOKINETICS OF AZAPROPAZONE FOLLOWING SINGLE ORAL AND INTRAVENOUS DOSESBREUING KH; GILFRICH HJ; MEINERTZ T et al.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 6; PP. 971-972; ABS. GER; BIBL. 9 REF.Article

HAEMODYNAMIC EFFECTS OF A SINGLE INTRAVENOUS DOSE OF LORCAINIDE IN PATIENTS WITH HEART DISEASEMEINERTZ T; KERSTING F; KASPER W et al.1980; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1980; VOL. 18; NO 6; PP. 461-465; BIBL. 8 REF.Article

Plasma concentrations of theophylline and quinine in healthy volunteers following oral administration of a fixed drug combinationDIETERICH, H. A; MESSER, W; JAEHNCHEN, E et al.Arzneimittel-Forschung. 1984, Vol 34, Num 4, pp 520-522, issn 0004-4172Article

DER INDIVIDUELLE FAKTOR IN DER ANTIARRHYTHMISCHEN THERAPIE AM BEISPIEL DES ANTIARRHYTHMIKUMS LORCAINID = LE FACTEUR INDIVIDUEL DANS LE TRAITEMENT ANTIARYTHMIQUE D'APRES L'EXEMPLE DE L'ANTIARYTHMIQUE LORCAINIDEMEINERTZ T; KASPER W; BECHTOLD H et al.1979; THERAPIEWOCHE; DEU; DA. 1979; VOL. 29; NO 42; PP. 6943-6964; (11 P.)Article

Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in manTRENK, D; WAGNER, F; SACHS, W et al.European journal of clinical pharmacology. 1989, Vol 37, Num 3, pp 313-316, issn 0031-6970, 4 p.Article

Pharmacokinetics of intravenous enoximone in dialysis patientsFIEGEL, P; TRENK, D; JAEHNCHEN, E et al.Journal of cardiovascular pharmacology. 1989, Vol 14, pp S20-S23, issn 0160-2446, suppl. 1Article

Enoximone versus dopamine in patients being weaned from cardiopulmonary bypassBIRNBAUM, D. E; PREUNER, J. G; GIESEKE, R et al.Cardiology. 1990, Vol 77, pp 34-41, issn 0008-6312, 8 p., suppl. 3Conference Paper

Lack of effect of enoximone on the pharmacokinetics of digoxin in patients with congestive heart failureTRENK, D; HERTRICH, F; WINKELMANN, B et al.Journal of clinical pharmacology. 1990, Vol 30, Num 3, pp 235-240, issn 0091-2700Article

Electrocardiographic and antiarrhythmic effects in intravenous amiodarone : results of a prospective, placebo-controlled studyHOHNLOSER, S. H; MEINERTZ, T; DAMMBACHER, T et al.The American heart journal. 1991, Vol 121, Num 1, pp 89-95, issn 0002-8703, 7 p., p.1Article